NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
ID: 348507Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348507

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-198.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the NIAID New Innovator Awards (DP2 Clinical Trial Not Allowed) to support early-stage, creative biomedical researchers proposing innovative research concepts in infectious diseases, immunology, and allergies. This grant opportunity is aimed at postdoctoral researchers and newly independent Early Stage Investigators, allowing them to request up to $300,000 annually for a maximum of five years to foster groundbreaking research that may not yet have sufficient preliminary data. Applications must be submitted through the Grants.gov platform by 5 PM local time on October 10, 2025, and will be evaluated based on significance, innovation, investigator qualifications, and overall impact. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-198-Full-Announcement.html
    PAR-23-198.html
    The NIAID New Innovator Awards, part of the NIH Director's New Innovator Awards program, targets early-stage, creative biomedical researchers with exceptional insights for impactful research in infectious diseases, immunology, and allergies. This funding opportunity (NOFO PAR-23-198) allows for applications proposing innovative, interdisciplinary research concepts. Eligible candidates include postdoctoral researchers or newly independent investigators with Early Stage Investigator status, who may request up to $300,000 annually for a maximum of five years. Submission of applications through the Grants.gov platform is mandated, alongside compliance with the updated NIH policies, including data sharing and resource management. Applications must describe the significance and innovation of proposed research, emphasizing creativity and the potential for major scientific advancements. Peer review evaluates the application’s significance, approach, investigator qualifications, and overall impact to determine funding merit. Key deadlines include the opening date on September 13, 2023, with applications due by 5 PM local time. The goal of this award is to foster groundbreaking research that may not yet have sufficient preliminary data, promoting independence and innovation among emerging researchers in the biomedical field.
    Similar Opportunities
    NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Career Transition Award (K22), a federal grant designed to support postdoctoral fellows in their transition to independent research scientist roles at academic institutions. This grant aims to assist candidates in developing independent research programs and applying for regular research grants, with a focus on enhancing the scientific workforce in biomedical research, particularly in infectious diseases. Eligible applicants include higher education institutions, nonprofits, and government agencies, with funding of up to $150,000 available for the first year and up to $100,000 for the second year, requiring a full-time commitment of at least 75% effort to research activities. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by January 7, 2028.
    NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) to support pioneering biomedical research focused on critical scientific challenges related to diabetes, digestive diseases, and kidney diseases. This grant aims to fund individual scientists proposing innovative and high-impact studies that diverge from their existing research, encouraging bold ideas and unconventional hypotheses within the domains of the Division of Diabetes, Endocrinology and Metabolic Diseases and the Division of Digestive Diseases and Nutrition. The award has a budget ceiling of $500,000 per year for a maximum project period of five years, with a total funding commitment of $4.8 million for FY 2026 to support up to six awards. Interested applicants must adhere to NIH registration requirements and submit their proposals by July 18, 2025, with further inquiries directed to grantsinfo@nih.gov.
    Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Innovation for HIV Vaccine Discovery" (NOFO Number PAR-23-169) aimed at supporting high-risk, high-impact early discovery research focused on innovative vaccine approaches to prevent HIV acquisition and ongoing infection. This initiative emphasizes a Go/No-Go funding approach, requiring applicants to demonstrate measurable progress towards defined goals by the end of Year 2, with continued funding contingent upon meeting these criteria. The overall budget for this initiative is approximately $2 million for fiscal year 2024, with individual project budgets capped at $350,000 per year, and applications must be submitted via Grants.gov by August 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Career Transition Award (K22), a federal grant aimed at supporting postdoctoral fellows in their transition to independent research positions, such as assistant professorships. This funding opportunity is specifically designed for applicants proposing research that does not involve leading independent clinical trials, although they may gain experience in existing clinical trials led by other investigators. The K22 award provides two years of funding, covering salary and research development costs, and is open to a diverse range of eligible applicants, including historically underrepresented institutions and organizations. Interested parties should note that the application deadline is January 7, 2025, and can find more information at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at supporting the transition of outstanding postdoctoral researchers with clinical doctorate degrees into independent research positions. This program seeks to address the national shortage of physician-scientists by providing a structured pathway that includes up to two years of mentored training followed by up to two years of independent research funding, contingent upon securing a tenure-track position. Eligible applicants include a diverse range of institutions such as higher education institutions, nonprofits, and certain health organizations, with applications evaluated based on the candidate's potential, career development plan, and the scientific merit of the proposed research. Interested parties should note that the application deadline is January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-071.html.
    NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at enhancing the number of independent physician-scientists in biomedical research. This program is specifically designed for outstanding postdoctoral researchers with clinical doctorate degrees who are transitioning from mentored positions to independent faculty roles, providing up to four years of funding divided into two phases: up to two years of mentored training followed by up to two years of independent research support. The initiative addresses the national shortage of physician-scientists and emphasizes the importance of a strong mentoring environment to facilitate successful transitions to research independence. Interested applicants must submit their proposals by January 7, 2026, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting applications for the Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) grant. This funding opportunity aims to support multi-project research initiatives that focus on infectious, immunologic, and allergic diseases, requiring each application to include at least two synergistic research projects and an administrative core, all centered around a common theme. The initiative is crucial for advancing research in areas such as the biology and pathogenesis of infectious microbes, immune system mechanisms, and the development of vaccines and therapeutics. Interested applicants must submit their proposals electronically via Grants.gov by September 7, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The funding amount is not limited but should reflect the actual needs of the proposed projects.
    NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), has announced a funding opportunity for the Clinical Trial Planning Grant (R34), aimed at supporting the planning and preparation necessary for investigator-initiated clinical trials. This grant encourages applications that focus on high-priority research aligned with NIAID's mission, providing funding of up to $150,000 for activities such as protocol development, study team establishment, and regulatory approvals. The opportunity is open to a diverse range of eligible applicants, including educational institutions, nonprofits, and governmental entities, with applications evaluated based on significance, innovation, and the research environment. Interested applicants should note that the application deadline is May 13, 2026, and can find more information at the provided NIH grants link or by contacting NIH Grants Information at grantsinfo@nih.gov.
    NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed), aimed at supporting early-stage researchers in oral, dental, and craniofacial research. This grant program is designed for new investigators who have not previously secured substantial NIH funding, encouraging them to conduct pilot studies and developmental research projects that will generate preliminary data for future R01 proposals. Eligible applicants include a variety of institutions, such as historically black colleges and universities, tribal colleges, and faith-based organizations, with each application able to request up to $200,000 for direct costs over a project duration of up to two years. Interested parties should note that the application deadline is January 7, 2028, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) to support innovative early-stage research projects that may lead to significant advancements in biomedical, behavioral, or clinical fields. This grant is designed to encourage high-risk, high-reward research, providing funding for projects that are distinct from traditional R01 grants, with a maximum budget of $275,000 over a two-year period, and no more than $200,000 in any single year. Eligible applicants include a wide range of organizations such as educational institutions, nonprofit organizations, and tribal governments, with applications undergoing a rigorous peer review process to assess their innovation and feasibility. Interested parties should note that the application submission period begins on January 16, 2025, with the opportunity closing on January 7, 2028; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.